Biotech company Cyclezyme is carrying out a directed new share issue that will bring the company approximately SEK 4 million before issue costs. Among the investors is CAIA Cosmetics co-founder Jesper Matsch, who is investing via Graciediaz. This is stated in a press release.The issue comprises 228,567 shares at a subscription price of SEK 17.50 per share and results in dilution of approximately 8.1 percent. "We are very pleased to welcome Jesper Matsch and the other investors to Cyclezyme. The issue not only strengthens our financial position but also brings in an ownership group with documented experience of building fast-growing companies and creating value. This gives us a stronger starting position as we now accelerate commercialization together with industrial partners." says Peter Falck, CEO of Cyclezyme.The capital will be used for continued development and commercialization of the company's enzyme-based technology for recycling plastics and textiles. The directed issue is carried out with support from the authorization from the annual general meeting on May 22.